xavGE
xavGE
xavGE
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
Foreign private issuers<br />
9.2 Direct equity share listing<br />
Cleary Gottlieb Steen & Hamilton LLP<br />
As discussed in Section 9.1, most foreign<br />
issuers that list equity in the United States<br />
do so using ADRs. ADRs were developed to<br />
facilitate custody and settlement for U.S.<br />
investors and the U.S. clearing system.<br />
A foreign private issuer may also list<br />
its shares directly on the NYSE without<br />
employing ADRs. This is common for<br />
Canadian companies, and major Dutch,<br />
German and Israeli issuers have also done<br />
so. An issuer that lists shares directly needs<br />
to establish a share registry system that<br />
effectively permits its shares to be quoted,<br />
traded and settled in the United States<br />
in U.S. dollars. To allow U.S. clearing and<br />
settlement without the intermediation<br />
of a depositary, the usual approach is to<br />
appoint a U.S. registrar that coordinates<br />
with the home country registrar using a<br />
continuously updated two-way electronic<br />
link between clearing systems. The<br />
mechanics can be complex, and the cost<br />
and time required to work them out can be<br />
a deterrent, especially for the first issuer<br />
to make these arrangements from a given<br />
jurisdiction.<br />
9.3 Description of IPO process timeline<br />
Cleary Gottlieb Steen & Hamilton LLP<br />
Every IPO is different, but most follow<br />
a broad pattern that breaks down into<br />
four phases. An aggressive but reasonable<br />
timeline might take 20 weeks: eight weeks<br />
to prepare materials for submission to the<br />
SEC, eight weeks to complete SEC review<br />
and then make a public filing, three weeks<br />
for marketing and a week to price and close<br />
the IPO.<br />
Several factors typically affect the<br />
length of the timeline. If the issuer will be<br />
dual-listed, the most important of these<br />
factors is the coordination of non-U.S.<br />
requirements with U.S. requirements,<br />
although with most non-U.S. regulators<br />
and exchanges there is ample precedent<br />
for managing this coordination. Another<br />
important factor is how much time the<br />
issuer and its auditors take to develop<br />
the information required by U.S. rules,<br />
especially financial statements that meet<br />
SEC requirements and an audit report that<br />
meets PCAOB standards. This can extend<br />
the first phase substantially.<br />
(a) Phase one—preparation<br />
During the first phase, the principal task<br />
is to prepare a draft registration statement<br />
on Form F-1. This includes the preliminary<br />
prospectus, which will be the principal<br />
document used to market the offering to<br />
investors. If the issuer is already listed<br />
in its home jurisdiction, the prospectus<br />
can draw on material the issuer already<br />
prepares for home-country reporting<br />
purposes, but the U.S. prospectus often will<br />
be quite different from what the issuer has<br />
previously published. If the issuer is going<br />
public in two jurisdictions at the same<br />
time, the coordination of the preparation<br />
process to address requirements in both<br />
jurisdictions, and sometimes in two<br />
languages, can be challenging.<br />
Unlike authorities in many other<br />
jurisdictions, the SEC requires an issuer to<br />
file its material contracts and certain other<br />
documents as exhibits to the registration<br />
statement, and these exhibits are publicly<br />
available. One priority for the first phase<br />
is to identify required exhibits and<br />
determine whether making them public<br />
presents any difficulties.<br />
The issuer should also use the<br />
preparation period to familiarize itself<br />
with the ongoing requirements applicable<br />
to companies registered with the SEC and<br />
to confirm the readiness of its reporting<br />
and compliance systems.<br />
The underwriters will typically use<br />
this period to conduct much of their due<br />
diligence, which includes management<br />
presentations, review of documentation<br />
and often other steps as well.<br />
Other items of documentation can be<br />
addressed during the preparation phase<br />
or later. These include working with the<br />
NYSE on listing qualifications, selecting a<br />
depositary and negotiating arrangements<br />
with it, preparing the separate registration<br />
statement on Form F-6 for the ADRs and<br />
negotiating the underwriting agreement.<br />
(b) Phase two—SEC review<br />
Following the preparatory phase, the<br />
issuer submits its substantially complete<br />
registration statement to the SEC<br />
for review and then responds to SEC<br />
comments, with the assistance of its<br />
U.S. counsel and its auditors. The SEC<br />
comment process can involve extensive<br />
back-and-forth discussion between<br />
the issuer and the SEC staff and the<br />
submission of successive amended<br />
registration statements. For a domestic<br />
U.S. issuer other than an emerging growth<br />
company, the successive versions of the<br />
registration statement are publicly filed.<br />
Most foreign issuers, however, go through<br />
the SEC review process on a confidential<br />
basis, without making the registration<br />
statement public at that time or disclosing<br />
that it has been submitted. (Confidential<br />
review is discussed in Section 9.5(a),<br />
below.) For a foreign private issuer that<br />
pursues a confidential review, the initial<br />
public filing usually occurs after the<br />
resolution of most or all SEC comments.<br />
During the SEC review period, the<br />
issuer and the underwriters also prepare<br />
for the roadshow, developing a roadshow<br />
presentation and itinerary. If the issuer<br />
qualifies as an emerging growth company<br />
under the JOBS Act (see Chapter 4),<br />
limited premarketing (often called “testing<br />
the waters”) is permitted before the<br />
registration statement is filed, although<br />
this has not yet become common practice.<br />
Otherwise, marketing does not begin<br />
until after the initial public filing of the<br />
registration statement.<br />
(c) Phase three—marketing<br />
The marketing period begins after the<br />
registration statement has been publicly<br />
filed, which is ordinarily after SEC<br />
comments have been resolved. If the<br />
issuer’s shares are not already trading<br />
(in its home market, for example), a<br />
price range for the offering must also be<br />
established before full marketing begins.<br />
The marketing phase often takes two<br />
or three weeks. It involves distributing the<br />
preliminary prospectus and conducting a<br />
roadshow with prospective investors based<br />
on an elaborate roadshow presentation.<br />
As marketing proceeds, the underwriters<br />
gather nonbinding indications of interest<br />
from investors—a process known as<br />
“bookbuilding.” After the conclusion of the<br />
roadshow, the issuer and the underwriters<br />
ask the SEC to declare the registration<br />
statement effective, which is required<br />
before the shares can be sold to investors.<br />
(d) Phase four—pricing and closing<br />
The bookbuilding process culminates in<br />
the pricing of the IPO, when the issuer<br />
(and any selling shareholder) agrees with<br />
the underwriters on the offering price and<br />
102 NYSE IPO Guide